Detailed information for compound 708298

Basic information

Technical information
  • TDR Targets ID: 708298
  • Name: N'-(2,5-dimethoxyphenyl)-N-[(3-methoxyphenyl) methyl]oxamide
  • MW: 344.362 | Formula: C18H20N2O5
  • H donors: 2 H acceptors: 2 LogP: 2.22 Rotable bonds: 9
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1cccc(c1)CNC(=O)C(=O)Nc1cc(OC)ccc1OC
  • InChi: 1S/C18H20N2O5/c1-23-13-6-4-5-12(9-13)11-19-17(21)18(22)20-15-10-14(24-2)7-8-16(15)25-3/h4-10H,11H2,1-3H3,(H,19,21)(H,20,22)
  • InChiKey: ZEUIJRBWEBZCBF-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • N'-(2,5-dimethoxyphenyl)-N-(3-methoxybenzyl)oxamide
  • N'-(2,5-dimethoxyphenyl)-N-[(3-methoxyphenyl)methyl]ethanediamide
  • ZINC04866918

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus granulosus neuropeptide receptor A26 0.0487 0.5157 1
Mycobacterium tuberculosis Probable imidazole glycerol-phosphate dehydratase HisB 0.0375 0.3846 1
Echinococcus granulosus survival motor neuron protein 1 0.0258 0.2482 0.4813
Echinococcus multilocularis neuropeptide s receptor 0.0487 0.5157 0.5157
Brugia malayi Iron-sulfur cluster assembly accessory protein 0.0053 0.0084 0.0339
Schistosoma mansoni hypothetical protein 0.018 0.1571 1
Echinococcus multilocularis geminin 0.018 0.1571 0.1571
Loa Loa (eye worm) hypothetical protein 0.0258 0.2482 1
Trichomonas vaginalis CMGC family protein kinase 0.0107 0.0716 1
Schistosoma mansoni serine/threonine protein kinase 0.0107 0.0716 0.4558
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0151 0.1228 0.782
Mycobacterium ulcerans imidazoleglycerol-phosphate dehydratase 0.0375 0.3846 1
Trypanosoma cruzi mitogen activated protein kinase 4, putative 0.0107 0.0716 1
Trichomonas vaginalis CMGC family protein kinase 0.0107 0.0716 1
Echinococcus granulosus mitogen activated protein kinase 3 0.0107 0.0716 0.1388
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0151 0.1228 0.2382
Brugia malayi MAP kinase sur-1 0.0107 0.0716 0.2884
Giardia lamblia Kinase, CMGC MAPK 0.0107 0.0716 0.5
Mycobacterium leprae Probable imidazole glycerol-phosphate dehydratase HisB 0.0185 0.1628 1
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0151 0.1228 0.1228
Echinococcus multilocularis mitogen activated protein kinase 3 0.0107 0.0716 0.0716
Leishmania major mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 0.0107 0.0716 1
Echinococcus granulosus neuropeptide s receptor 0.0487 0.5157 1
Brugia malayi GTP-binding regulatory protein Gs alpha-S chain, putative 0.0151 0.1228 0.4948
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0151 0.1228 0.1228
Trypanosoma brucei protein kinase, putative 0.0107 0.0716 1
Loa Loa (eye worm) CMGC/MAPK/ERK1 protein kinase 0.0107 0.0716 0.2884
Echinococcus granulosus mitogen activated protein kinase 0.0107 0.0716 0.1388
Echinococcus multilocularis neuropeptide receptor A26 0.0487 0.5157 0.5157
Leishmania major mitogen activated protein kinase, putative,map kinase, putative 0.0107 0.0716 1
Trypanosoma cruzi mitogen-activated protein kinase 11, putative 0.0107 0.0716 1
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0151 0.1228 0.782
Echinococcus multilocularis calcium activated potassium channel 0.0046 0.0011 0.0011
Toxoplasma gondii CMGC kinase, MAPK family (ERK) MAPK-1 0.0107 0.0716 1
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0151 0.1228 0.2382
Onchocerca volvulus 0.0053 0.0084 1
Trypanosoma cruzi mitogen-activated protein kinase 11, putative 0.0107 0.0716 1
Trichomonas vaginalis CMGC family protein kinase 0.0107 0.0716 1
Brugia malayi hypothetical protein 0.0258 0.2482 1
Trypanosoma brucei mitogen activated protein kinase 4, putative 0.0107 0.0716 1
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0151 0.1228 0.782
Mycobacterium tuberculosis Class a beta-lactamase BlaC 0.0148 0.1193 0.2525
Echinococcus multilocularis survival motor neuron protein 1 0.0258 0.2482 0.2482
Schistosoma mansoni hypothetical protein 0.0053 0.0084 0.0535
Loa Loa (eye worm) GTP-binding regulatory protein Gs alpha-S chain 0.0151 0.1228 0.4948
Echinococcus multilocularis mitogen activated protein kinase 0.0107 0.0716 0.0716
Schistosoma mansoni survival motor neuron protein 0.0053 0.0084 0.0535
Echinococcus granulosus geminin 0.018 0.1571 0.3045
Mycobacterium ulcerans class a beta-lactamase, BlaC 0.0148 0.1193 0.2525
Schistosoma mansoni hypothetical protein 0.018 0.1571 1
Trichomonas vaginalis CMGC family protein kinase 0.0107 0.0716 1
Echinococcus granulosus calcium activated potassium channel 0.0046 0.0011 0.0022
Trypanosoma cruzi mitogen activated protein kinase 2, putative 0.0107 0.0716 1
Trypanosoma brucei beta lactamase 0.0071 0.0297 0.4145

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.